J33 — HCPCS Level II Codes
- J3300 Injection, triamcinolone acetonide, preservative free, 1 mg billable
- J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg billable
- J3302 Injection, triamcinolone diacetate, per 5 mg billable
- J3303 Injection, triamcinolone hexacetonide, per 5 mg billable
- J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg billable
- J3315 Injection, triptorelin pamoate, 3.75 mg billable
- J3316 Injection, triptorelin, extended-release, 3.75 mg billable
- J3350 Injection, urea, up to 40 gm billable
- J3357 Ustekinumab, for subcutaneous injection, 1 mg billable
- J3358 Ustekinumab, for intravenous injection, 1 mg billable
- J3360 Injection, diazepam, up to 5 mg billable
- J3373 Injection, vancomycin hydrochloride, 10 mg billable
- J3374 Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg billable
- J3375 Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg billable
- J3376 Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg billable
- J3379 Injection, valproate sodium, 5 mg billable
- J3380 Injection, vedolizumab, intravenous, 1 mg billable
- J3385 Injection, velaglucerase alfa, 100 units billable
- J3386 Injection, etuvetidigene autotemcel, per treatment billable
- J3387 Injection, elivaldogene autotemcel, per treatment billable
- J3389 Topical administration, prademagene zamikeracel, per treatment billable
- J3391 Injection, atidarsagene autotemcel, per treatment billable
- J3392 Injection, exagamglogene autotemcel, per treatment billable
- J3393 Injection, betibeglogene autotemcel, per treatment billable
- J3394 Injection, lovotibeglogene autotemcel, per treatment billable
- J3396 Injection, verteporfin, 0.1 mg billable
- J3397 Injection, vestronidase alfa-vjbk, 1 mg billable
- J3398 Injection, voretigene neparvovec-rzyl, 1 billion vector genomes billable
- J3399 Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes billable